当前位置: X-MOL 学术medRxiv. Ophthalmol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The effect of sample medication use on subsequent anti-VEGF agent selection for neovascular age-related macular degeneration
medRxiv - Ophthalmology Pub Date : 2021-07-30 , DOI: 10.1101/2021.07.27.21261104
Karen M Wai , Tedi Begaj , Sachi Patil , Evan Chen , John B Miller , Jan Kylstra , Mary E Aronow , Lucy H Young , Rachel Huckfeldt , Deeba Husain , Leo A Kim , Demetrios G Vavvas , Dean Eliott , Shizuo Mukai , Evangelos S Gragoudas , Nimesh A Patel , Lucia Sobrin , Joan W Miller , Ravi Parikh , David M Wu

Purpose To examine the effect of medication sample use (ranibizumab or aflibercept) on future anti-vascular endothelial growth factor (VEGF) agent selection in neovascular age-related macular degeneration (nvAMD).

中文翻译:

样本药物使用对后续抗VEGF药物选择对新生血管性年龄相关性黄斑变性的影响

目的检查药物样本使用(雷珠单抗或阿柏西普)对未来新生血管性年龄相关性黄斑变性 (nvAMD) 中抗血管内皮生长因子 (VEGF) 药物选择的影响。
更新日期:2021-08-03
down
wechat
bug